# Pasithea Therapeutics Corp.: Form 8-K, filed Dec 28, 2023

- Company: [Pasithea Therapeutics Corp.](/companies/ktta.md) (CIK 1841330)
- Form: 8-K
- Filed: 2023-12-28
- Accepted by EDGAR: Dec 28, 2023, 11:30 ET
- Period: 2023-12-28
- Accession: 0001213900-23-099115
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1841330/000121390023099115/ea190815-8k_pasithea.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841330/000121390023099115/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841330/000121390023099115/ea190815-8k_pasithea.htm

Filed Dec 28, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-099115. Last ingested by Listed: Nov 6, 2026, 16:36 ET. No prices; not investment advice.